Leaders in the Drug Repositioning and Repurposing Field to Meet for 6th Annual Drug Repositioning Conference in Chicago in June 2017

Share Article

Arrowhead Publishers is pleased to announce that the 6th Annual Drug Repositioning, Repurposing and Rescue Conference will be taking place June 27-28, 2017 in Chicago, IL.

Arrowhead Publishers is pleased to announce that the 6th Annual Drug Repositioning, Repurposing and Rescue Conference will be taking place June 27-28, 2017 in Chicago, IL. This event will provide a platform for a variety of stakeholders furthering drug development through a variety of collaborations, including patient advocacy efforts and industry/academic/government cooperation. For more information, visit: http://www.drugrepositioningconference.com/index/download-brochure.

This year’s conference will be focused on the use of repurposing to find and develop new therapies for rare diseases. Several key themes at this event will include

  • Patient Advocacy Efforts: Emphasis on and engagement with patient advocacy groups, who are investigating in drug repositioning efforts to an unprecedented degree
  • New Partnerships: The conference will explore how new partnerships between various groups, including government, industry and academia are teaming up to advance repurposing efforts
  • Commercial Case Studies: Leaders in drug repositioning will discuss their successes, failures and the way forward
  • Collaborative efforts: Government/academic/industry collaborations will be explored and highlighted in order to determine how disparate groups can achieve success
  • Systematic Repositioning and Data Analytics: Repurposing is no longer based on serendipity as more and more companies are designing tools to streamline and increase the odds of success

Featured Speakers Include:

  • Ronald Alfa, MD, Ph.D., Vice President, Discovery and Product, Recursion Pharmaceuticals 
  • Bobbie Ann Austin, Ph.D., Program Officer, Drug Development Partnership Programs, National Center for Advancing Translational Sciences (NCATS), Office of the Director, National Institutes of Health
  • Pieter Dylst, Senior Manager Market Access and Value Added Medicines, Medicines for Europe
  • Laura Kleiman, Ph.D., Scientific Research Director, cBio Center, Dana-Farber Cancer Institute
  • Daphna Laifenfeld, Ph.D., Sr. Director, Personalized & Predictive Medicine, Teva Pharmaceutical Industries
  • Kevin Pan, Ph.D., Chief Executive Officer, Asieris Pharmaceuticals
  • Aris Persidis, Ph.D., President, Biovista
  • Michael Pollastri, Ph.D., Associate Professor & Chair, Northeastern University, College of Science
  • Vidula Sukhatme, Founder and CEO, Global Cures

Please visit http://www.drugrepositioningconference.com/index/speakers for the full speaking faculty.

For more information, please contact:
John Waslif: Managing Director
Arrowhead Publishers
866-945-0263 ext 700
john.waslif(at)arrowheadpublishers.com

Rachel Donlon: Marketing Associate
Arrowhead Publishers
866-945-0263 ext 701
rachel.donlon(at)arrowheadpublishers.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Rachel Donlon
Arrowhead Publishers and Conferences
+1 (952) 807-6819
Email >